SCHEMBL4877523

SCHEMBL4877523

CCCC(CN1CCCCCCCCCCCCC1)N1CCCCCCCCCCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
MITF O75030 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
PAX8 Q06710 1/20 0.43
SLC6A4 P31645 4/20 0.37
MAPT P10636 5/20 0.37
ALDH1A1 P00352 4/20 0.37
XBP1 P17861 1/20 0.37
HTT P42858 2/20 0.36
HRH3 Q9Y5N1 1/20 0.35
ATM Q13315 1/20 0.34
SLC6A3 Q01959 6/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
HSD17B10 Q99714 2/20 0.34
LMNA P02545 1/20 0.34
SLC6A2 P23975 4/20 0.33
ANPEP P15144 1/20 0.33
ERAP2 Q6P179 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4858545 0.88 HRH3 (0.42) KMT2AMEN1MITFRAB9ASMN1; SMN2
SCHEMBL3302667 0.84 SLC6A3 (0.38) SLC6A4HRH3SLC6A3SLC6A2
SCHEMBL898138 0.82 SLC6A3 (0.39) SLC6A4HRH3SLC6A3SLC6A2
SCHEMBL23866055 0.80 SLC6A3 (0.36) SLC6A4HRH3SLC6A3SLC6A2
SCHEMBL3300015 0.80 SLC6A3 (0.36) SLC6A4HRH3SLC6A3SLC6A2
SCHEMBL23733432 0.80 SLC6A3 (0.36) SLC6A4HRH3SLC6A3SLC6A2
Iodide SCHEMBL15008876 0.80 SLC6A3 (0.38) SLC6A4HRH3SLC6A3SLC6A2
Iodide SCHEMBL10559193 0.78 SLC6A3 (0.35) SLC6A4HRH3SLC6A3SLC6A2
Ammonia Solution, Strong SCHEMBL464958 0.78 SLC6A3 (0.35) SLC6A4HRH3SLC6A3SLC6A2
Bromide SCHEMBL11218003 0.78 SLC6A3 (0.35) SLC6A4HRH3SLC6A3SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3720494-A2 DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS Magenta Therapeutics, Inc. (US) 2020-10-14 EP disclosed
WO-2019113375-A2 DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS Magenta Therapeutics, Inc. (US) 2019-06-13 WO disclosed
EP-1991221-A2 METHODS FOR INCREASING BLOOD FLOW AND/OR PROMOTING TISSUE REGENERATION Genzyme Corporation (US) 2008-11-19 EP disclosed
WO-2007106063-A2 METHODS FOR INCREASING BLOOD FLOW AND/OR PROMOTING TISSUE REGENERATION GENZYME CORPORATION (US) 2007-09-20 WO disclosed